Lexaria Bioscience Accounts Payable

Lexaria Bioscience (LEXX) currently reports a accounts payable of $350K as of May 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Lexaria Bioscience's accounts payable history and peer comparisons.

Lexaria Bioscience's accounts payable changed from $0 to $350K (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lexaria Bioscience reported $350K in accounts payable as of May 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $350K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lexaria Bioscience, and consider following LEXX for alerts when major investors trade the stock.

Lexaria Bioscience is classified in the Healthcare sector. On accounts payable, it currently shows $350K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LEXX with unrelated industries.